Outcomes of patients with anemia and renal dysfunction in hospitalized heart failure with preserved ejection fraction (from the CN-HF registry)

Autor: Xinchun Yang, Kai Hu, Micheal Fu, Yu Song, Junbo Ge, Xuejuan Jin, Yuyuan Fan, Dingli Xu, Wei Dong, Zhenyue Chen, Jun Zhou, Liwen Li, Qiaoqing Zhong, Yanyan Wang, Jingmin Zhou, Juan Cao, Xueting Han, Li Chen, Cn-Hf investigators
Rok vydání: 2019
Předmět:
MRA
mineralocorticoid receptor antagonist

lcsh:Diseases of the circulatory (Cardiovascular) system
medicine.medical_specialty
AF
atrial fibrillation

Anemia
LDL
low density lipoprotein cholesterol

HFpEF
heart failure with preserved ejection fraction

NT-proBNP
N-terminal pro-brain natriuretic peptide

Heart failure
030204 cardiovascular system & hematology
HF
Heart failure

Nyha class
RD
renal dysfunction

03 medical and health sciences
0302 clinical medicine
Internal medicine
LVEF
left ventricular ejection fraction

LVDD
left ventricular diastolic dimension

Medicine
In patient
CN-HF
China National Heart Failure Registration Study

030212 general & internal medicine
NYHA
New York Heart Association

HFrEF
heart failure with reduced ejection fraction

TC
serum total cholesterol

ARB
angiotensin receptor blockers

Original Paper
BNP
brain natriuretic peptide

Ejection fraction
TG
triglyceride

business.industry
Proportional hazards model
eGFR
estimated glomerular filtration rate

CRFs
case report forms

ACEI
angiotensin converting enzyme inhibitors

medicine.disease
HR
hazard ratio

HDL
high density lipoprotein cholesterol

CI
confidence interval

Clinical trial
Heart failure with preserved ejection fraction
lcsh:RC666-701
Cardiology
Renal dysfunction
Cardiology and Cardiovascular Medicine
business
Zdroj: International Journal of Cardiology. Heart & Vasculature
International Journal of Cardiology: Heart & Vasculature, Vol 25, Iss, Pp-(2019)
ISSN: 2352-9067
DOI: 10.1016/j.ijcha.2019.100415
Popis: Background: Although a large number of studies on heart failure with reduced ejection fraction (HFrEF) have found that anemia and renal dysfunction (RD) independently predicted poor outcomes, there are still few reports on patients with heart failure with preserved ejection fraction (HFpEF). Methods: Clinical data of HFpEF patients registered in the China National Heart Failure Registration Study (CN-HF) were evaluated and the clinical features of patients with or without anemia/RD were compared to explore the impact of anemia and RD on all-cause mortality and all-cause re-hospitalization. Results: 1604 patients with HFpEF were enrolled, the prevalence of anemia was 51.0%. Although anemia was associated with increased risk of all-cause mortality and all-cause re-hospitalization in univariate COX regression (p
Databáze: OpenAIRE